Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), could affect brain structure and function. SARS-CoV …

Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …

Background Cognitive deficits are among the main disabling symptoms in COVID-19
patients and post-COVID syndrome (PCS). Within brain regions, the hippocampus, a key …

The presence of symptoms after an acute SARS-CoV-2 infection (long-COVID) has become
a worldwide healthcare emergency but remains underestimated and undertreated due to a …

With the decline in the number of new Severe Acute Respiratory Syndrome Coronavirus 2
(SARS‐CoV‐2) infections, the World Health Organization announced the end of the SARS …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persists throughout the
world with over 65 million registered cases of survivors with post-COVID-19 sequelae, also …

Background Long COVID or post-COVID condition (PCC) is a common complication
following acute COVID-19 infection. PCC is a multi-systems disease with neurocognitive …

Long COVID syndrome, also known as post-acute sequelae of COVID-19 (PASC), is
characterized by persistent symptoms lasting 3–12 weeks post SARS-CoV-2 infection …

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), has
emerged as a significant health concern following the COVID-19 pandemic. Molecular …

As of March 2023, over 761 million confirmed cases of coronavirus disease 2019 (COVID-
19) have been confirmed worldwide, leading to more than 6.8 million deaths. 1 Although …